Hazardous Drug Exposures in Health Care
Health care workers who prepare or administer hazardous drugs (e.g., those used for cancer therapy, and some antiviral drugs, hormone agents, and bioengineered drugs) or who work in areas where these drugs are used may be exposed to these agents in the workplace. About 5.5 million U.S. health care workers are potentially exposed to hazardous drugs, including pharmacy and nursing personnel, physicians, environmental services workers, workers in research laboratories, veterinary care workers, and shipping and receiving personnel.
It seems counter-intuitive that the health care industry, whose mission is the care of the sick, is itself a "high-hazard" industry for the workers it employs. In fact, published studies have shown that workplace exposures to hazardous drugs can cause both acute and chronic health effects such as skin rashes, adverse reproductive outcomes (including infertility, spontaneous abortions, and congenital malformations), and possibly leukemia and other cancers. The health risk depends on how much exposure a worker has to these drugs and how toxic they are. Workers can be protected from exposures to hazardous drugs through engineering and administrative controls, and proper protective equipment.
Public Meeting on Updating the NIOSH List of Hazardous DrugsAugust 28, 2007 9am - 4pm
Marriott Metro Center Hotel
775 12th St. NW
Washington, DC 20005
See more information at http://www.cdc.gov/niosh/review/public/105/default.htmlFederal Register Notice
If you have any questions regarding hazardous drugs please submit them to firstname.lastname@example.org.
Workplace Solutions: Medical Surveillance for Health Care Workers Exposed to Hazardous Drugs
DHHS (NIOSH) Publication No. 2007-124 (2007)
Livestock producers, veterinarians, and other workers may be exposed to the toxic hazards of the animal antibiotic Micotil 300® through needlestick injuries, skin cuts, puncture wounds, and contact with skin and mucous membranes.
Alert: Preventing Occupational Exposures to Antineoplastic and other Hazardous
Drugs in Healthcare Settings